TELIX PHARMACEUTICALS
DEAD

Serial Number

79214379

Owner

Telix Pharmaceuticals Pty Ltd

Filing Date

May 30, 2017

Add to watchlist:

No watchlists yet
View on USPTO

TELIX PHARMACEUTICALS Trademark

Serial Number: 79214379

TELIX PHARMACEUTICALS is a trademark filed by Telix Pharmaceuticals Pty Ltd on May 30, 2017. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Telix Pharmaceuticals Pty Ltd (2 trademarks)

Suite 401,

Entity Type: 99

Trademark Details

Filing Date

May 30, 2017

Registration Date

Not Registered

Goods & Services

licensing of intellectual property

Scientific research; scientific research in the field of pharmacy; research on the subject of pharmaceuticals; medical research; research and development of products; providing scientific advisory services relating to immunological products; provision of scientific information in the fields of biochemistry, biotechnology and clinical trials; scientific consultancy, namely, consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science; all of the aforementioned in relation to radiopharmaceuticals and cancer

Advertising services; business advisory services relating to product development; business consultancy; retail or wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialisation of goods, namely, procuring of contracts for third parties for the purchase and sale of goods

Apparatus for administering pharmaceuticals, namely, medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for the treatment of cancer; imaging apparatus for medical use for diagnosing medical conditions; drug delivery systems, namely, applicators for pharmaceutical preparations sold without medication; all of the aforementioned for use in the detection or treatment of cancer

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
NOTIFICATION PROCESSED BY IB
Sep 11, 2022 GPNX
NEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2022 NREP
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 15, 2021 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Oct 3, 2021 LIMG
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Aug 15, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jul 31, 2021 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 17, 2020 OPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 10, 2020 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Dec 26, 2019 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 26, 2019 FICR
REFUSAL PROCESSED BY IB
Jul 12, 2019 RFNT
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Dec 26, 2018 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Dec 26, 2018 ABN0
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 4, 2018 ERFR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 9, 2018 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Sep 20, 2018 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 27, 2018 ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 26, 2018 ADCH
FINAL REFUSAL MAILED
Jun 6, 2018 CNFR
FINAL REFUSAL WRITTEN
Jun 5, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 28, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2018 TROA
REFUSAL PROCESSED BY IB
Sep 22, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 1, 2017 RFCS
REFUSAL PROCESSED BY MPU
Sep 1, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 30, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 29, 2017 CNRT
ASSIGNED TO EXAMINER
Aug 28, 2017 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 22, 2017 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 17, 2017 REPR